Literature DB >> 23975633

Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors.

Shu-Hong Li1, Wei Wei, Rong-Ping Guo, Ming Shi, Zhi-Xing Guo, Zhi-Yuan Chen, Cheng-Zuo Xiao, Mu-Yan Cai, Lie Zheng.   

Abstract

The long-term outcome and prognostic factors after curative in patients with single hepatocellular carcinoma (HCC) without macrovascular invasion are still unclear. The objective of this study is to evaluate the effect of curative resection on survival and analyze the prognostic clinicopathologic factors, especially the presence of microvascular invasion (MVI), in these patients. Two hundred and sixty consecutive patients with single HCC without macrovascular invasion who underwent curative resection from December 2004 to December 2007 were retrospectively reviewed in this study. Survival rates were calculated by using the Kaplan-Meier method. Univariate and multivariate analyses of 14 clinicopathologic factors were performed to determine the significant prognostic factors. No patient died within 1 month after the operation. The 1-, 3-, and 5-year overall survival rates after curative resection were 96.54, 83.46, and 74.01%, respectively. Multivariate analysis revealed that only the presence of MVI was an independent negative prognostic factor affecting overall survival. The 1-, 3-, and 5-year disease-free survival rates were 79.62, 62.69, and 56.01%, respectively. The presence of MVI was the only independent unfavorable prognostic factor for disease-free survival. According to our analysis, patients with single HCC without macrovascular invasion after curative resection can be expected to have considerable long-term survival. The presence of MVI was an independent negative prognostic factor for both overall survival and disease-free survival. To improve the prognosis, these patients should be followed up more carefully and might be good candidates for adjuvant therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23975633     DOI: 10.1007/s12032-013-0696-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  30 in total

1.  Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center.

Authors:  Jie Wang; Lei-Bo Xu; Chao Liu; Hao-Wei Pang; Ya-Jin Chen; Qing-Jia Ou
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

2.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.

Authors:  Xiao-Ping Chen; Fa-Zu Qiu; Zai-De Wu; Zhi-Wei Zhang; Zhi-Yong Huang; Yi-Fa Chen; Bi-Xiang Zhang; Song-Qing He; Wan-Guang Zhang
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

4.  Outcome after partial hepatectomy for hepatocellular cancer within the Milan criteria.

Authors:  S T Fan; R T P Poon; C Yeung; C M Lam; C M Lo; W K Yuen; K K C Ng; C L Liu; S C Chan
Journal:  Br J Surg       Date:  2011-06-07       Impact factor: 6.939

5.  Triple positive tumor markers for hepatocellular carcinoma are useful predictors of poor survival.

Authors:  Shigehisa Kiriyama; Kazuhisa Uchiyama; Masaki Ueno; Satoru Ozawa; Shinya Hayami; Masaji Tani; Hiroki Yamaue
Journal:  Ann Surg       Date:  2011-12       Impact factor: 12.969

6.  Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma.

Authors:  Jae Min Chun; Hyung Jun Kwon; Junho Sohn; Sang Geol Kim; Ji-Young Park; Han Ik Bae; Young Kook Yun; Yoon Jin Hwang
Journal:  J Surg Oncol       Date:  2010-12-22       Impact factor: 3.454

7.  Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade.

Authors:  L Zhou; J-A Rui; S-B Wang; S-G Chen; Q Qu
Journal:  Eur J Surg Oncol       Date:  2011-04-29       Impact factor: 4.424

8.  The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin.

Authors:  Ken Shirabe; Shinji Itoh; Tomoharu Yoshizumi; Yuji Soejima; Akinobu Taketomi; Shin-Ichi Aishima; Yoshihiko Maehara
Journal:  J Surg Oncol       Date:  2007-03-01       Impact factor: 3.454

9.  Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection.

Authors:  Lian-Yue Yang; Feng Fang; Di-Peng Ou; Wei Wu; Zhi-Jun Zeng; Fan Wu
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

10.  Outcomes of hepatic resection for a single large hepatocellular carcinoma.

Authors:  Yong Beom Cho; Kuhn Uk Lee; Hae Won Lee; Eung-Ho Cho; Sung-Hoon Yang; Jai Young Cho; Nam-Joon Yi; Kyung-Suk Suh
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

View more
  7 in total

1.  Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).

Authors:  Juxian Sun; Rongping Guo; Xinyu Bi; Mengchao Wu; Zhaoyou Tang; Wan Yee Lau; Shusen Zheng; Xuehao Wang; Jinming Yu; Xiaoping Chen; Jia Fan; Jiahong Dong; Yongjun Chen; Yunfu Cui; Chaoliu Dai; Chihua Fang; Shuang Feng; Zhili Ji; Weidong Jia; Ningyang Jia; Gong Li; Jing Li; Qiu Li; Jiangtao Li; Tingbo Liang; Lianxin Liu; Shichun Lu; Yi Lv; Yilei Mao; Yan Meng; Zhiqiang Meng; Feng Shen; Jie Shi; Huichuan Sun; Kaishan Tao; Gaojun Teng; Xuying Wan; Tianfu Wen; Liqun Wu; Jinglin Xia; Mingang Ying; Jian Zhai; Leida Zhang; Xuewen Zhang; Zhiwei Zhang; Haiping Zhao; Donghai Zheng; Xuting Zhi; Jie Zhou; Cuncai Zhou; Jian Zhou; Zhaochong Zeng; Kangshun Zhu; Minshan Chen; Jianqiang Cai; Shuqun Cheng
Journal:  Liver Cancer       Date:  2022-03-17       Impact factor: 12.430

2.  Prognostic Factors and Clinical Characteristics for Hepatocellular Carcinoma Patients with Benign Enlarged Perihepatic Lymph Nodes: a Single-Center Experience from China.

Authors:  Fei Tian; Jian-Xiong Wu; Wei-Bo Yu
Journal:  J Gastrointest Surg       Date:  2015-08-11       Impact factor: 3.452

Review 3.  Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition.

Authors:  Shuqun Cheng; Minshan Chen; Jianqiang Cai
Journal:  Oncotarget       Date:  2017-01-31

Review 4.  Surgical resection for hepatocellular carcinoma with portal vein tumor thrombus in the Asia-Pacific region beyond the Barcelona Clinic Liver Cancer treatment algorithms: a review and update.

Authors:  Jia-Zhou Ye; Yan-Yan Wang; Tao Bai; Jie Chen; Bang-De Xiang; Fei-Xiang Wu; Le-Qun Li
Journal:  Oncotarget       Date:  2017-06-27

5.  Effect of surgical margin on postoperative prognosis in patients with solitary hepatocellular carcinoma: A propensity score matching analysis.

Authors:  Zewen Zhou; Lunan Qi; Qiuyan Mo; Yingchun Liu; Xianguo Zhou; Zihan Zhou; Xiumei Liang; Shixiong Feng; Hongping Yu
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

6.  Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis.

Authors:  Yongjie Shui; Wei Yu; Xiaoqiu Ren; Yinglu Guo; Jing Xu; Tao Ma; Bicheng Zhang; Jianjun Wu; Qinghai Li; Qiongge Hu; Li Shen; Xueli Bai; Tingbo Liang; Qichun Wei
Journal:  Radiat Oncol       Date:  2018-09-25       Impact factor: 3.481

7.  Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.

Authors:  Wei Wei; Pei-En Jian; Shao-Hua Li; Zhi-Xing Guo; Yong-Fa Zhang; Yi-Hong Ling; Xiao-Jun Lin; Li Xu; Ming Shi; Lie Zheng; Min-Shan Chen; Rong-Ping Guo
Journal:  Cancer Commun (Lond)       Date:  2018-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.